The molecular respiratory panels market size is projected to be worth US$ 1.1 billion in 2023. The market is likely to surpass US$ 2.0 billion by 2033 at a CAGR of 6.3% during the forecast period. The rising incidence of respiratory infections, including viral outbreaks such as influenza and the COVID-19 pandemic, is a major driving force behind the demand for molecular respiratory panels’. These panels’ offer rapid and accurate diagnosis, enabling timely treatment and infection control measures.
Other Drivers Propelling the Demand for Molecular Respiratory Panels Market include:
Challenges for Companies /Manufacturers in the Molecular Respiratory Panels Market:
Opportunities in the Molecular Respiratory Panels Market Industry:
Latest Trends in the Molecular Respiratory Panels Market:
| Attributes | Details |
|---|---|
| Molecular Respiratory Panels Market Size (2023) | US$ 1.1 billion |
| Molecular Respiratory Panels Market Projected Size (2033) | US$ 2.0 billion |
| Value CAGR (2023 to 2033) | 6.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global molecular respiratory panels’ market experienced a CAGR of 9.2%, reaching a market size of US$ 1.1 million in 2023.
From 2017 to 2022, the global molecular respiratory panels’’ market industry witnessed steady growth due to the increased prevalence of respiratory illnesses and technological advancements. Significant advances in molecular diagnostic technology have occurred throughout the years, including the creation of polymerase chain reaction (PCR) and other nucleic acid amplification techniques. These technological improvements have enhanced the sensitivity, specificity, and multiplexing capabilities of molecular respiratory panels’, which has contributed to the growth of the market.
Respiratory diseases, such as influenza, respiratory syncytial virus (RSV), and other respiratory pathogens, have long been a source of worry across the world. The growing prevalence of these illnesses has increased need for reliable and speedy diagnostic tests, propelling the molecular respiratory panels’ market forward.
Future Forecast for Molecular Respiratory Panels Market Industry:
Looking ahead, the global molecular respiratory panels’’ market industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 2.0 billion by 2033.
The molecular respiratory panels’’ market industry is expected to continue its growth trajectory from 2023 to 2033. As the benefits and capabilities of molecular respiratory panels’ become more generally recognized, healthcare practitioners are likely to become more aware and employ them. The requirement for accurate and quick diagnosis, as well as infection management and monitoring, will drive the expansion of the molecular respiratory panel market.
The requirement for quick results and decentralized testing will push the need for point-of-care testing to expand further. Molecular respiratory panels’ that may be conducted at the point of treatment, such as in clinics or emergency rooms, are expected to acquire market traction.
| Country | The United States |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 575.6 million |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
The molecular respiratory panels’’ market industry in the United States is expected to reach a market size of US$ 575.6 million by 2033, expanding at a CAGR of 7.0%. The incidence of chronic respiratory disorders in the nation is increasing, which is driving up demand for the industry. For instance, the USA Centers for Disease Control and Prevention (CDC) 2022 report showed that in 8 out of 10 public health districts in the USA, the prevalence of respiratory syncytial virus (RSV) is rising.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 73.6 million |
| CAGR % 2023 to End of Forecast (2033) | 5.3% |
The molecular respiratory panels’’ market industry in the United Kingdom is expected to reach a market share of US$ 73.6 million, expanding at a CAGR of 5.3% during the forecast period. Strict laws for the mining sector increase the usage of the molecular respiratory panels’. In the EU there are around 53,000 people employed by coal power stations. The EU’s regulatory body also conducts routine checkups of these workers, which boosts demand for molecular respiratory panels’.
| Country | China |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 180.6 million |
| CAGR % 2023 to End of Forecast (2033) | 7.7% |
The molecular respiratory panels’’ market industry in China is anticipated to reach a market size of US$ 180.6 million, moving at a CAGR of 7.7% during the forecast period. The molecular respiratory panel’s market industry in China is expected to grow prominently due to the increasing population with respiratory illness. China has a big population, and respiratory illnesses such as influenza, Respiratory syncytial (RSV), and other respiratory pathogens are common. The rising prevalence of these illnesses is raising the requirement for precise and effective diagnostic techniques such as molecular respiratory panels’.
| Country | Japan |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 126.0 million |
| CAGR % 2023 to End of Forecast (2033) | 7.4% |
The molecular respiratory panels’ market industry in Japan is estimated to reach a market size of US$ 126.0 million by 2033, thriving at a CAGR of 7.4%. The market in Japan is predicted to grow because of high geriatric population. Japan has one of the world's oldest populations, and respiratory illnesses such as pneumonia and influenza are widespread among the elderly. The growing older population in Japan, as well as the requirement for precise respiratory illness detection, are projected to boost demand for molecular respiratory panels.
| Country | South Korea |
|---|---|
| Market Size (US$ Million) by End of Forecast Period (2033) | US$ 49.3 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The molecular respiratory panels’ market industry in South Korea is expected to reach a market size of US$ 49.3 million, expanding at a CAGR of 6.8% during the forecast period. In the past, South Korea has had outbreaks of respiratory illnesses such as MERS (Middle East Respiratory Syndrome) and COVID-19. These incidents have raised public awareness of respiratory illnesses, resulting in a greater demand for reliable market data.
Principal Consultant
The multiplex panels is to dominate the molecular respiratory panels’ market industry with a market share of 50.4% in 2022. A multiplex molecular diagnostic platform would be a crucial component of a successful respiratory diagnostics method. For the identification of respiratory infections, NADT methods such as loop-mediated isothermal amplification and nucleic acid sequence-based amplification have been utilized.
Multiplexing, in which numerous targets are evaluated at the same time, is often used in PCR-based assays and offers substantial advantages in terms of efficiency and pathogen coverage over single-pathogen tests.
Diagnostic use is dominating the molecular respiratory panels’ market industry with market share of 65.8% in 2022. Molecular respiratory panels are generally used for diagnostic reasons since they are designed to detect and identify respiratory pathogens at the molecular level, delivering accurate and speedy findings for respiratory infection diagnosis.
Reverse transcription polymerase chain reaction (RT-PCR) is dominating the molecular respiratory panels’ market with the market share of 47.8% in 2022. RT-PCR may identify very low quantities of viral genetic material in patient samples. This great sensitivity enables for the early diagnosis of viral infections, even when the viral load is low in the early stages of the disease. It facilitates accurate diagnosis and patient management. This technique's great sensitivity is particularly appealing to healthcare professionals and individuals seeking to diagnose.
The diagnostic centers dominating the molecular respiratory panels’ market with the market share of 38.1% in 2022. Diagnostic centers often utilize molecular respiratory panels as part of their comprehensive testing services for respiratory infections. These panels offer several advantages, such as the ability to simultaneously test for multiple respiratory pathogens in a single assay, high sensitivity and specificity, and rapid turnaround times.
The molecular respiratory panel sector is aggressively competitive, with many companies fighting for market dominance. Key players in the molecular respiratory panels market employ various strategies to stay competitive and maintain their market position.
Key Strategies Used by the Participants
Key players invest in research and development activities to continuously improve their molecular respiratory panel products. By offering innovative and advanced products, companies can attract customers and differentiate themselves from competitors.
Key players form strategic partnerships and collaborations with other companies, academic institutions, and research organizations. These partnerships facilitate the exchange of knowledge, resources, and technologies, leading to the development of new products and solutions.
Companies focus on expanding their presence in different geographic regions. This involves establishing distribution channels, partnerships with local distributors, and obtaining necessary regulatory approvals in target markets.
Companies in the market may engage in mergers or acquisitions to consolidate their product portfolio, acquire new technologies, these strategic moves allow companies to enter new market segments, gain access to novel products or intellectual property, and achieve synergies in terms of research, manufacturing, or distributions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Molecular Respiratory Panels Market:
The market is anticipated to expand at a 6.3% CAGR from 2023 to 2033.
The market totals US$ 1.1 billion in 2023.
Asia Pacific is expected to be a lucrative market.
High equipment limits the market growth.
From 2017 to 2022, the market held a 9.2% CAGR.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USPs 4.3. Technological Roadmap 4.4. Recent Product Approvals/Launches 4.5. Regulatory Landscape 4.6. PESTEL Analysis 4.7. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Medical Device Outlook 5.1.3. Global Life Expectancy Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Growing Awareness about Respiratory Diseases 5.2.3. Favourable Government Regulations 5.2.4. Technological Advancement 5.2.5. Increasing Prevalence of Respiratory Diseases 5.2.6. Frequency of Product Approvals 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2017 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Panel Type 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Panel Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Panel Type, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Panel Type, 2023 to 2033 9.3.1. Multiplex Panels 9.3.2. Syndromic Panels 9.3.3. Targeted Panels 9.4. Market Attractiveness Analysis By Panel Type 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Usage Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Usage Type, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Usage Type, 2023 to 2033 10.3.1. Diagnostic Use 10.3.2. Research Use 10.4. Market Attractiveness Analysis By Usage Type 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technique 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By Technique, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Technique, 2023 to 2033 11.3.1. Polymerase Chain Reaction (PCR) 11.3.2. Reverse Transcription Polymerase Chain Reaction (RT-PCR) 11.3.3. Real-time Polymerase Chain Reaction (qPCR) 11.3.4. Next-Generation Sequencing (NGS) 11.4. Market Attractiveness Analysis By Technique 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 12.3.1. Hospitals 12.3.2. Diagnostic Centers 12.3.3. Academic & Research Institutions 12.3.4. Ambulatory Diagnostic Centers 12.4. Market Attractiveness Analysis By End User 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Panel Type 14.3.3. By Usage 14.3.4. By Technique 14.3.5. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Panel Type 14.4.3. By Usage 14.4.4. By Technique 14.4.5. By End User 14.5. Country Level Analysis & Forecast 14.5.1. USA Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Panel Type 14.5.1.2.2. By Usage 14.5.1.2.3. By Technique 14.5.1.2.4. By End User 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Panel Type 14.5.2.2.2. By Usage 14.5.2.2.3. By Technique 14.5.2.2.4. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Panel Type 15.3.3. By Usage 15.3.4. By Technique 15.3.5. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Panel Type 15.4.3. By Usage 15.4.4. By Technique 15.4.5. By End User 15.5. Country Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Panel Type 15.5.1.2.2. By Usage 15.5.1.2.3. By Technique 15.5.1.2.4. By End User 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Panel Type 15.5.2.2.2. By Usage 15.5.2.2.3. By Technique 15.5.2.2.4. By End User 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Panel Type 15.5.3.2.2. By Usage 15.5.3.2.3. By Technique 15.5.3.2.4. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. UK 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Rest of Europe 16.3.2. By Panel Type 16.3.3. By Usage 16.3.4. By Technique 16.3.5. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Panel Type 16.4.3. By Usage 16.4.4. By Technique 16.4.5. By End User 16.5. Country Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Panel Type 16.5.1.2.2. By Usage 16.5.1.2.3. By Technique 16.5.1.2.4. By End User 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Panel Type 16.5.2.2.2. By Usage 16.5.2.2.3. By Technique 16.5.2.2.4. By End User 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Panel Type 16.5.3.2.2. By Usage 16.5.3.2.3. By Technique 16.5.3.2.4. By End User 16.5.4. UK Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Panel Type 16.5.4.2.2. By Usage 16.5.4.2.3. By Technique 16.5.4.2.4. By End User 16.5.5. Spain Market Analysis 16.5.5.1. Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Panel Type 16.5.5.2.2. By Usage 16.5.5.2.3. By Technique 16.5.5.2.4. By End User 16.5.6. Russia Market Analysis 16.5.6.1. Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Panel Type 16.5.6.2.2. By Usage 16.5.6.2.3. By Technique 16.5.6.2.4. By End User 16.5.7. BENELUX Market Analysis 16.5.7.1. Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Panel Type 16.5.7.2.2. By Usage 16.5.7.2.3. By Technique 16.5.7.2.4. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Panel Type 17.3.3. By Usage 17.3.4. By Technique 17.3.5. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Panel Type 17.4.3. By Usage 17.4.4. By Technique 17.4.5. By End User 17.5. Country Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Panel Type 17.5.1.2.2. By Usage 17.5.1.2.3. By Technique 17.5.1.2.4. By End User 17.5.2. Thailand Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Panel Type 17.5.2.2.2. By Usage 17.5.2.2.3. By Technique 17.5.2.2.4. By End User 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Panel Type 17.5.3.2.2. By Usage 17.5.3.2.3. By Technique 17.5.3.2.4. By End User 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Panel Type 17.5.4.2.2. By Usage 17.5.4.2.3. By Technique 17.5.4.2.4. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Panel Type 18.3.3. By Usage 18.3.4. By Technique 18.3.5. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Panel Type 18.4.3. By Usage 18.4.4. By Technique 18.4.5. By End User 18.5. Country Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Panel Type 18.5.1.2.2. By Usage 18.5.1.2.3. By Technique 18.5.1.2.4. By End User 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Panel Type 18.5.2.2.2. By Usage 18.5.2.2.3. By Technique 18.5.2.2.4. By End User 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Panel Type 18.5.3.2.2. By Usage 18.5.3.2.3. By Technique 18.5.3.2.4. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Panel Type 19.3.3. By Usage 19.3.4. By Technique 19.3.5. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Panel Type 19.4.3. By Usage 19.4.4. By Technique 19.4.5. By End User 19.5. Country Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Panel Type 19.5.1.2.2. By Usage 19.5.1.2.3. By Technique 19.5.1.2.4. By End User 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Panel Type 19.5.2.2.2. By Usage 19.5.2.2.3. By Technique 19.5.2.2.4. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Panel Type 20.3.3. By Usage 20.3.4. By Technique 20.3.5. By End User 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Panel Type 20.4.3. By Usage 20.4.4. By Technique 20.4.5. By End User 20.5. Country Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Panel Type 20.5.1.2.2. By Usage 20.5.1.2.3. By Technique 20.5.1.2.4. By End User 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Panel Type 20.5.2.2.2. By Usage 20.5.2.2.3. By Technique 20.5.2.2.4. By End User 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Panel Type 20.5.3.2.2. By Usage 20.5.3.2.3. By Technique 20.5.3.2.4. By End User 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Panel Type 20.5.4.2.2. By Usage 20.5.4.2.3. By Technique 20.5.4.2.4. By End User 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Roche Diagnostics 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Key Financials 22.3.1.4. Sales Footprint 22.3.1.5. SWOT Analysis 22.3.1.6. Strategy Overview 22.3.1.6.1. Marketing Strategy 22.3.1.6.2. Product Strategy 22.3.1.6.3. Channel Strategy 22.3.2. Siemens Healthineers 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Key Financials 22.3.2.4. Sales Footprint 22.3.2.5. SWOT Analysis 22.3.2.6. Strategy Overview 22.3.2.6.1. Marketing Strategy 22.3.2.6.2. Product Strategy 22.3.2.6.3. Channel Strategy 22.3.3. Advanced Molecular Diagnostics (AMD) 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Key Financials 22.3.3.4. Sales Footprint 22.3.3.5. SWOT Analysis 22.3.3.6. Strategy Overview 22.3.3.6.1. Marketing Strategy 22.3.3.6.2. Product Strategy 22.3.3.6.3. Channel Strategy 22.3.4. Illumina Inc. 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Key Financials 22.3.4.4. Sales Footprint 22.3.4.5. SWOT Analysis 22.3.4.6. Strategy Overview 22.3.4.6.1. Marketing Strategy 22.3.4.6.2. Product Strategy 22.3.4.6.3. Channel Strategy 22.3.5. Helvetica Healthcare 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Key Financials 22.3.5.4. Sales Footprint 22.3.5.5. SWOT Analysis 22.3.5.6. Strategy Overview 22.3.5.6.1. Marketing Strategy 22.3.5.6.2. Product Strategy 22.3.5.6.3. Channel Strategy 22.3.6. Qiagen 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Key Financials 22.3.6.4. Sales Footprint 22.3.6.5. SWOT Analysis 22.3.6.6. Strategy Overview 22.3.6.6.1. Marketing Strategy 22.3.6.6.2. Product Strategy 22.3.6.6.3. Channel Strategy 22.3.7. Jant Pharmacal Corporation 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Key Financials 22.3.7.4. Sales Footprint 22.3.7.5. SWOT Analysis 22.3.7.6. Strategy Overview 22.3.7.6.1. Marketing Strategy 22.3.7.6.2. Product Strategy 22.3.7.6.3. Channel Strategy 22.3.8. Trivitron Healthcare 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Key Financials 22.3.8.4. Sales Footprint 22.3.8.5. SWOT Analysis 22.3.8.6. Strategy Overview 22.3.8.6.1. Marketing Strategy 22.3.8.6.2. Product Strategy 22.3.8.6.3. Channel Strategy 22.3.9. Thermo Fisher Scientific 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Key Financials 22.3.9.4. Sales Footprint 22.3.9.5. SWOT Analysis 22.3.9.6. Strategy Overview 22.3.9.6.1. Marketing Strategy 22.3.9.6.2. Product Strategy 22.3.9.6.3. Channel Strategy 22.3.10. Cepheid 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Key Financials 22.3.10.4. Sales Footprint 22.3.10.5. SWOT Analysis 22.3.10.6. Strategy Overview 22.3.10.6.1. Marketing Strategy 22.3.10.6.2. Product Strategy 22.3.10.6.3. Channel Strategy 22.3.11. Bioneer Corporation 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Key Financials 22.3.11.4. Sales Footprint 22.3.11.5. SWOT Analysis 22.3.11.6. Strategy Overview 22.3.11.6.1. Marketing Strategy 22.3.11.6.2. Product Strategy 22.3.11.6.3. Channel Strategy 22.3.12. BioFire Diagnostics (Biomerieux) 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Key Financials 22.3.12.4. Sales Footprint 22.3.12.5. SWOT Analysis 22.3.12.6. Strategy Overview 22.3.12.6.1. Marketing Strategy 22.3.12.6.2. Product Strategy 22.3.12.6.3. Channel Strategy 22.3.13. Antylia Scientific Company 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Key Financials 22.3.13.4. Sales Footprint 22.3.13.5. SWOT Analysis 22.3.13.6. Strategy Overview 22.3.13.6.1. Marketing Strategy 22.3.13.6.2. Product Strategy 22.3.13.6.3. Channel Strategy 22.3.14. Quidel Corporation 22.3.14.1. Overview 22.3.14.2. Product Portfolio 22.3.14.3. Key Financials 22.3.14.4. Sales Footprint 22.3.14.5. SWOT Analysis 22.3.14.6. Strategy Overview 22.3.14.6.1. Marketing Strategy 22.3.14.6.2. Product Strategy 22.3.14.6.3. Channel Strategy 22.3.15. DTPM 22.3.15.1. Overview 22.3.15.2. Product Portfolio 22.3.15.3. Key Financials 22.3.15.4. Sales Footprint 22.3.15.5. SWOT Analysis 22.3.15.6. Strategy Overview 22.3.15.6.1. Marketing Strategy 22.3.15.6.2. Product Strategy 22.3.15.6.3. Channel Strategy 22.3.16. Luminex Corporation (DiaSorin) 22.3.16.1. Overview 22.3.16.2. Product Portfolio 22.3.16.3. Key Financials 22.3.16.4. Sales Footprint 22.3.16.5. SWOT Analysis 22.3.16.6. Strategy Overview 22.3.16.6.1. Marketing Strategy 22.3.16.6.2. Product Strategy 22.3.16.6.3. Channel Strategy 22.3.17. Bio-Rad Laboratories. 22.3.17.1. Overview 22.3.17.2. Product Portfolio 22.3.17.3. Key Financials 22.3.17.4. Sales Footprint 22.3.17.5. SWOT Analysis 22.3.17.6. Strategy Overview 22.3.17.6.1. Marketing Strategy 22.3.17.6.2. Product Strategy 22.3.17.6.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Molecular Respiratory Panels Market
